Form 4: Ardent Health Partners CEO Martin Bonick Reports Stock Transactions

Ardent Health Partners' CEO, Martin Bonick, reports the withholding of shares for tax obligations and the acquisition of restricted stock units.

Summary

• On March 31, 2025, Martin Bonick, the President and CEO of Ardent Health Partners, had 12,970 shares of common stock withheld for payment of taxes upon vesting of restricted stock units at a price of $13.75 per share.
• Following this transaction, Bonick directly owned 992,057 shares of common stock.
• On April 1, 2025, Bonick acquired 134,927 restricted stock units.
• These restricted stock units vest in three substantially equal installments on each anniversary of April 1, 2025, subject to continued service with the Issuer.
• Following this transaction, Bonick directly owned 1,126,984 shares of common stock.
• The report was signed by Stephen C. Petrovich, Attorney-in-Fact, on April 2, 2025.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.

Future Outlook

The restricted stock units vest in three substantially equal installments on each anniversary of April 1, 2025, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date.

Industry Context

This is a standard SEC Form 4 filing, reflecting changes in beneficial ownership by a company insider. Such filings are common and provide transparency to the market regarding insider transactions.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions, which can influence investor confidence.

Key Dates

Keywords

Ardent Health Partners, Martin Bonick, Stock Transactions, Restricted Stock Units, Form 4, Beneficial Ownership